Thank you for subscribing
Preview text: Thank you for subscribing 96 Thank you for subscribing to our newsletter. You will receive…
Image not available
No image available for this email.
- Subject
- Thank you for subscribing
- Preview text
- Thank you for subscribing 96 Thank you for subscribing to our newsletter. You will receive…
- From
- operations@
axolbio.com - Brand
- Axol Bioscience
- ESP
- HubSpot
- Sent
- Thu Jul 2, 2026, 2:16 PM ET
- Sent to
- United Kingdom (axolbio.co.uk)
- Size
- 18 KB
- Images
- 1
- Links
- 2, 1 of them buttons
- Subject length
- 25 characters
Against Axol Bioscience's usual
Sent in its busiest hour, 2 PM, which holds 50% of its emails. The subject is 25 characters; its average is 57.
Email headers
What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.
- From
- Axol Bioscience <[email protected]>
- Reply-To
- [email protected]
- Subject
- Thank you for subscribing
- Date
- Thu, 2 Jul 2026 19:16:58 +0100
- Message-ID domain
- bf06x.hubspotemail.net
- Return-Path domain
- bf06x.hubspotemail.net
- DKIM signature
- d=bf06x.hubspotemail.net s=hs2; d=axolbio.com s=hs1-6097189
- List-Unsubscribe
- Present, one-click
- Feedback-ID sender
- HubSpot
Servers it passed through, newest first
- from 4f2ou7.bf06x.hubspotemail.net [108.179.149.209] by our receiving server with ESMTPS
Other sending headers (names only): X-HS-Cid, X-Report-Abuse-To
Sent just before and after
| Jul 27, 2026 12:33 PM | PRISM ALS: New stem cell models to transform research into treatments for MND/ALS | |
| Jul 11, 2026 12:54 PM | Thank you for subscribing | |
| Jul 2, 2026 2:33 PM | Physiologically relevant human iPSC-derived models and specialist services | |
| Jul 2, 2026 2:16 PM | Thank you for subscribing (this email) | |
| Jun 29, 2026 8:30 AM | Physiologically relevant human iPSC-derived models | |
| May 29, 2026 2:48 PM | iPSC-derived models and New Approach Methodologies (NAMs) | |
| Apr 30, 2026 2:01 PM | Physiologically relevant iPSC-derived retinal models for ophthalmology research & drug discovery |